NCT00382070 2024-03-22Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast CancerNSABP Foundation IncPhase 3 Unknown3,966 enrolled 12 charts
NCT03633331 2021-10-15Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast CancerAlliance for Clinical Trials in OncologyPhase 2 Unknown93 enrolled 8 charts